Th17 cytokines induce pro-fibrotic cytokines release from human eosinophils

Respiratory Research

Volumn 14, Issue 1, 2013, Pages

  Al Muhsen, Saleh ^a   Letuve, Severine ^b   Vazquez Tello, Alejandro ^a   Pureza, Mary Angeline ^a   Al Jahdali, Hamdan ^a,c   Bahammam, Ahmed S ^a   Hamid, Qutayba ^d   Halwani, Rabih ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b INSERM   (France)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Asthma; Eosinophils; IL 11; Pro fibrotic cytokines; TGF ; Th17 cytokines

Indexed keywords

INTERLEUKIN 11; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE; INTERLEUKIN 17;

ADULT; ARTICLE; ASTHMA; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; MALE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TH1 CELL; TH17 CELL; TH2 CELL; BRONCHUS; FIBROSIS; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION;

ADULT; ASTHMA; BRONCHI; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; FEMALE; FIBROSIS; HUMANS; INFLAMMATION; INTERLEUKIN-11; INTERLEUKIN-17; MALE; POLYMERASE CHAIN REACTION; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84874794220     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-14-34     Document Type: Article

References (50)

1. Vignola AM, Mirabella F, Costanzo G, Di Giorgi R, Gjomarkaj M, Bellia V, Bonsignore G. Airway remodeling in asthma. Chest 2003, 123:417S-422S. 10.1378/chest.123.3_suppl.417S, 12629009.
2. Vignola AM, Kips J, Bousquet J. Tissue remodeling as a feature of persistent asthma. J Allergy Clin Immunol 2000, 105:1041-1053. 10.1067/mai.2000.107195, 10856134.
3. Benayoun L, Druilhe A, Dombret MC, Aubier M, Pretolani M. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 2003, 167:1360-1368. 10.1164/rccm.200209-1030OC, 12531777.
4. Sumi Y, Hamid Q. Airway remodeling in asthma. Allergol Int 2007, 56:341-348. 10.2332/allergolint.R-07-153, 17965577.
5. Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989, 1:520-524.
6. Parameswaran K, Willems-Widyastuti A, Alagappan VK, Radford K, Kranenburg AR, Sharma HS. Role of extracellular matrix and its regulators in human airway smooth muscle biology. Cell Biochem Biophys 2006, 44:139-146. 10.1385/CBB:44:1:139, 16456242.
7. Minshall EM, Leung DY, Martin RJ, Song YL, Cameron L, Ernst P, Hamid Q. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1997, 17:326-333.
8. Flood-Page P, Menzies-Gow A, Phipps S, Ying S, Wangoo A, Ludwig MS, Barnes N, Robinson D, Kay AB. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003, 112:1029-1036. 198522, 14523040.
9. Vignola AM, Chanez P, Chiappara G, Merendino A, Pace E, Rizzo A, la Rocca AM, Bellia V, Bonsignore G, Bousquet J. Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 1997, 156:591-599.
10. Minshall E, Chakir J, Laviolette M, Molet S, Zhu Z, Olivenstein R, Elias JA, Hamid Q. IL-11 expression is increased in severe asthma: association with epithelial cells and eosinophils. J Allergy Clin Immunol 2000, 105:232-238. 10.1016/S0091-6749(00)90070-8, 10669841.
11. Cho JY, Miller M, Baek KJ, Han JW, Nayar J, Lee SY, McElwain K, McElwain S, Friedman S, Broide DH. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest 2004, 113:551-560. 338264, 14966564.
12. Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003, 167:199-204. 10.1164/rccm.200208-789OC, 12406833.
13. Barczyk A, Pierzchala W, Sozanska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med 2003, 97:726-733. 10.1053/rmed.2003.1507, 12814161.
14. Oda N, Canelos PB, Essayan DM, Plunkett BA, Myers AC, Huang SK. Interleukin-17 F induces pulmonary neutrophilia and amplifies antigen-induced allergic response. Am J Respir Crit Care Med 2005, 171:12-18.
15. Chang Y, Al-Alwan L, Risse PA, Roussel L, Rousseau S, Halayko AJ, Martin JG, Hamid Q, Eidelman DH. TH17 cytokines induce human airway smooth muscle cell migration. J Allergy Clin Immunol 2011, 127:1046-1053. e1041-1042, 10.1016/j.jaci.2010.12.1117, 21345484.
16. Cheung PF, Wong CK, Lam CW. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17 F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. J Immunol 2008, 180:5625-5635.
17. Dubois GR, Schweizer RC, Versluis C, Bruijnzeel-Koomen CA, Bruijnzeel PL. Human eosinophils constitutively express a functional interleukin-4 receptor: interleukin-4 -induced priming of chemotactic responses and induction of PI-3 kinase activity. Am J Respir Cell Mol Biol 1998, 19:691-699.
18. Riedel D, Lindemann A, Brach M, Mertelsmann R, Herrmann F. Granulocyte-macrophage colony-stimulating factor and interleukin-3 induce surface expression of interleukin-2 receptor p55-chain and CD4 by human eosinophils. Immunology 1990, 70:258-261. 1384203, 2197216.
19. Lajoie-Kadoch S, Joubert P, Letuve S, Halayko AJ, Martin JG, Soussi-Gounni A, Hamid Q. TNF-alpha and IFN-gamma inversely modulate expression of the IL-17E receptor in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2006, 290:L1238-L1246. 10.1152/ajplung.00301.2005, 16428271.
20. Letuve S, Lajoie-Kadoch S, Audusseau S, Rothenberg ME, Fiset PO, Ludwig MS, Hamid Q. IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts. J Allergy Clin Immunol 2006, 117:590-596. 10.1016/j.jaci.2005.10.025, 16522458.
21. Kuhn C, Homer RJ, Zhu Z, Ward N, Flavell RA, Geba GP, Elias JA. Airway hyperresponsiveness and airway obstruction in transgenic mice. Morphologic correlates in mice overexpressing interleukin (IL)-11 and IL-6 in the lung. Am J Respir Cell Mol Biol 2000, 22:289-295.
22. Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Page N, Olivenstein R, Elias J, Chakir J. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001, 108:430-438. 10.1067/mai.2001.117929, 11544464.
23. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med 2000, 162:2341-2351.
24. Hansel TT, De Vries IJ, Iff T, Rihs S, Wandzilak M, Betz S, Blaser K, Walker C. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991, 145:105-110. 10.1016/0022-1759(91)90315-7, 1662676.
25. Yamaguchi Y, Hayashi Y, Sugama Y, Miura Y, Kasahara T, Kitamura S, Torisu M, Mita S, Tominaga A, Takatsu K. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med 1988, 167:1737-1742. 10.1084/jem.167.5.1737, 2188945, 2835420.
26. Okada S, Hagan JB, Kato M, Bankers-Fulbright JL, Hunt LW, Gleich GJ, Kita H. Lidocaine and its analogues inhibit IL-5-mediated survival and activation of human eosinophils. J Immunol 1998, 160:4010-4017.
27. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
28. Herrick CA, Bottomly K. To respond or not to respond: T cells in allergic asthma. Nat Rev Immunol 2003, 3:405-412. 10.1038/nri1084, 12766762.
29. Al-Ramli W, Prefontaine D, Chouiali F, Martin JG, Olivenstein R, Lemiere C, Hamid Q. T(H)17-associated cytokines (IL-17A and IL-17 F) in severe asthma. J Allergy Clin Immunol 2009, 123:1185-1187. 10.1016/j.jaci.2009.02.024, 19361847.
30. Truyen E, Coteur L, Dilissen E, Overbergh L, Dupont LJ, Ceuppens JL, Bullens DM. Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients. Thorax 2006, 61:202-208. 10.1136/thx.2005.052399, 2080739, 16449261.
31. Halwani R, Al-Muhsen S, Al-Jahdali H, Hamid Q. Role of transforming growth factor-beta in airway remodeling in asthma. Am J Respir Cell Mol Biol 2011, 44:127-133. 10.1165/rcmb.2010-0027TR, 20525803.
32. Qin H, Wang L, Feng T, Elson CO, Niyongere SA, Lee SJ, Reynolds SL, Weaver CT, Roarty K, Serra R. TGF-beta promotes Th17 cell development through inhibition of SOCS3. J Immunol 2009, 183:97-105. 10.4049/jimmunol.0801986, 2851540, 19535626.
33. Morishima N, Mizoguchi I, Takeda K, Mizuguchi J, Yoshimoto T. TGF-beta is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23. Biochem Biophys Res Commun 2009, 386:105-110. 10.1016/j.bbrc.2009.05.140, 19501566.
34. Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, Oukka M, Kuchroo VK, Hafler DA. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008, 454:350-352. 10.1038/nature07021, 2760130, 18469800.
35. Starnes T, Robertson MJ, Sledge G, Kelich S, Nakshatri H, Broxmeyer HE, Hromas R. Cutting edge: IL-17 F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol 2001, 167:4137-4140.
36. Roussel L, Houle F, Chan C, Yao Y, Berube J, Olivenstein R, Martin JG, Huot J, Hamid Q, Ferri L, Rousseau S. IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J Immunol 2010, 184:4531-4537. 10.4049/jimmunol.0903162, 20228195.
37. Elovic AE, Ohyama H, Sauty A, McBride J, Tsuji T, Nagai M, Weller PF, Wong DT. IL-4-dependent regulation of TGF-alpha and TGF-beta1 expression in human eosinophils. J Immunol 1998, 160:6121-6127.
38. Wen FQ, Liu X, Kobayashi T, Abe S, Fang Q, Kohyama T, Ertl R, Terasaki Y, Manouilova L, Rennard SI. Interferon-gamma inhibits transforming growth factor-beta production in human airway epithelial cells by targeting Smads. Am J Respir Cell Mol Biol 2004, 30:816-822.
39. Shen ZJ, Esnault S, Rosenthal LA, Szakaly RJ, Sorkness RL, Westmark PR, Sandor M, Malter JS. Pin1 regulates TGF-beta1 production by activated human and murine eosinophils and contributes to allergic lung fibrosis. J Clin Invest 2008, 118:479-490. 2176187, 18188456.
40. Tsai JJ, Kao MH, Han SH. The respiratory burst activity of activated eosinophils in atopic asthmatics. Int Arch Allergy Immunol 1999, 119:38-44. 10.1159/000024173, 10341319.
41. Durham SR, Loegering DA, Dunnette S, Gleich GJ, Kay AB. Blood eosinophils and eosinophil-derived proteins in allergic asthma. J Allergy Clin Immunol 1989, 84:931-936. 10.1016/0091-6749(89)90391-6, 2480971.
42. Pignatti P, Perfetti L, Galdi E, Pozzi V, Bossi A, Biale C, Moscato G. Increased CD69 expression on peripheral blood eosinophils after specific inhalation challenge. Allergy 2002, 57:411-416. 10.1034/j.1398-9995.2002.23454.x, 11972480.
43. Ciprandi G, Cuppari C, Salpietro AM, Tosca MA, Rigoli L, Grasso L, La Rosa M, Marseglia GL, Del Giudice MM, Salpietro C. Serum IL-23 strongly and inversely correlates with FEV1 in asthmatic children. Int Arch Allergy Immunol 2012, 159:183-186.
44. Ciprandi G, Cuppari C, Salpietro C. Serum IL-23: a surrogate biomarker for asthma?. Clin Exp Allergy 2012, 42:1416-1417. author reply 1418, 10.1111/j.1365-2222.2012.04068.x, 22925327.
45. Halwani R, Al-Muhsen S, Hamid Q. T helper 17 cells in airway diseases: from laboratory bench to bedside. Chest 2013, 143:494-501. 10.1378/chest.12-0598, 23381314.
46. Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 2009, 9:556-567. 10.1038/nri2586, 2821718, 19575028.
47. Rahman MS, Yamasaki A, Yang J, Shan L, Halayko AJ, Gounni AS. IL-17A induces eotaxin-1/CC chemokine ligand 11 expression in human airway smooth muscle cells: role of MAPK (Erk1/2, JNK, and p38) pathways. J Immunol 2006, 177:4064-4071.
48. Xiao YQ, Freire-de-Lima CG, Schiemann WP, Bratton DL, Vandivier RW, Henson PM. Transcriptional and translational regulation of TGF-beta production in response to apoptotic cells. J Immunol 2008, 181:3575-3585. 2583327, 18714031.
49. Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet 2009, 373:1905-1917. 10.1016/S0140-6736(09)60326-3, 19482216.
50. Cuenda A, Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 2007, 1773:1358-1375. 10.1016/j.bbamcr.2007.03.010, 17481747.